Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 7:18 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 409–432 of 1,484 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Scheduling Clear all

Conditions: Cystic Fibrosis
Interventions: Colistin, Tobramycin; Drug
Lead sponsor: National Jewish Health; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Heart Failure With Reduced Ejection Fraction
Interventions: HekaHeart platform medication management and remote monitoring; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Guilford, Connecticut • New Haven, Connecticut

Conditions: Amyloid Light-chain Amyloidosis
Interventions: BCMA bispecific; Drug
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 2
States / cities: Rochester, Minnesota • Cleveland, Ohio

Conditions: Hyperparathyroidism
Interventions: 99mTc-MIBI planar imaging and SPECT/CT., F- 18PSMA PET/CT imaging study; Diagnostic Test
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 3
States / cities: Atlanta, Georgia • Johns Creek, Georgia

Conditions: Cancer Risk Syndrome
Interventions: AYA-RISE Adolescents and Young Adults Risk Information and Screening Education, Standard clinical visit for genetic counseling; Behavioral
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 12 Years to 24 Years
Enrollment: 115 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 5
States / cities: Atlanta, Georgia • Chicago, Illinois • Boston, Massachusetts + 1 more

Conditions: Benign Prostatic Hyperplasia
Interventions: Embosphere Microspheres, HoLEP Procedure; Device · Procedure
Lead sponsor: University of Miami; Other
Eligibility: 50 Years and older · Male only
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Arthritis Foot, Trauma Injury, Deformity; Bone
Interventions: NanoBone Bone Graft Substitute; Other
Lead sponsor: Artoss Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 8
States / cities: Scottsdale, Arizona • Sarasota, Florida • Joliet, Illinois + 5 more

Conditions: Screening Colonoscopies
Interventions: Educational intervention, Routine Care Instructions; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 45 Years and older
Enrollment: 155 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Metastatic Prostate Carcinoma, Stage III Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8
Interventions: Patient Navigation, Genetic Counseling, Survey Administration, Best Practice; Behavioral · Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Castration-resistant Prostate Cancer
Interventions: AR Blockade, Carotuximab; Drug
Lead sponsor: Edwin Posadas, MD; Other
Eligibility: 18 Years and older · Male only
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 3
States / cities: Duarte, California • Los Angeles, California • Salt Lake City, Utah

Conditions: Revision Spine Surgery, Fusion of Spine, Cervical Fusion, Lumbar Fusion
Interventions: Ketamine Hydrochloride; Drug
Lead sponsor: AXIS Spine Center- a division of Northwest Specialty Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Coeur d'Alene, Idaho

Conditions: Upper GI Bleeding
Interventions: HemoPill, Endoscopy; Device · Procedure
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 99 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity
Interventions: VLM-S, VLM-M, OGR; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 21 Years to 75 Years
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Spinal Cord Injuries, Polytrauma, Burns
Interventions: placebo; Other
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Lung Cancer (Diagnosis)
Interventions: Virtual Navigation System; Diagnostic Test
Lead sponsor: Penn State University; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: High Grade Glioma, Glioblastoma
Interventions: BDTX-1535, BDTX-1535 combined with radiation therapy, BDTX-1535 combined with temozolomide and radiation therapy; Drug
Lead sponsor: St. Joseph's Hospital and Medical Center, Phoenix; Other
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Chandler, Arizona • Phoenix, Arizona

Conditions: Behavioral Health
Interventions: Pre-intake appointment informational messages; Behavioral
Lead sponsor: Geisinger Clinic; Other
Eligibility: 18 Years and older
Enrollment: 6,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: Developmental Language Disorder, Specific Language Impairment, Language Development
Interventions: Retrieval-based word learning: Expanding retrieval practice schedule, Retrieval-based word learning: Standard retrieval practice schedule; Behavioral
Lead sponsor: Purdue University; Other
Eligibility: 48 Months to 71 Months
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Short Bowel Syndrome
Interventions: Teduglutide 0.05mg/kg, Teduglutide 0.025 mg/kg, Standard of Care; Drug · Other
Lead sponsor: Shire; Industry
Eligibility: 0 Years to 17 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 18
States / cities: Los Angeles, California • San Francisco, California • Washington D.C., District of Columbia + 14 more

Conditions: Opioid Use Disorder
Interventions: Buprenorphine; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Breast Cancer
Interventions: Hypofractionated radiotherapy, Pembrolizumab infusion, Blood and tissue sampling; Radiation · Drug · Procedure
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Breast Cancer
Interventions: FFDM Mammography, DBT Mammography; Device
Lead sponsor: Fujifilm Medical Systems USA, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 1,232 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 5
States / cities: Scottsdale, Arizona • Iowa City, Iowa • Rochester, New York + 2 more

Conditions: Asthma
Interventions: Intervention Subjects; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 1 Year to 18 Years
Enrollment: 439 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Fabry Disease
Interventions: Venglustat (GZ402671), Agalsidase alfa, Agalsidase beta (GZ419828), Migalastat; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 8
States / cities: Birmingham, Alabama • Los Angeles, California • Atlanta, Georgia + 5 more

Search by objective public record fields.

IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy

Evaluation of the HekaHeart Platform in Medication Management for Heart Failure Patients

Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis

F-18 PSMA for Localization of Parathyroid Adenoma

Intervention For Adolescents and Young Adults (AYAs) With Cancer Risk Syndromes

Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate

Artoss Foot and Ankle Surgery Registry

Bowel Preparation Quality for Screening Colonoscopy

Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation

Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc

Pre-Operative Ketamine Infusion for Post Operative Pain Control After Revision Spinal Surgery

Presence or Absence of Blood in the GI Lumen

Online Counseling to Enable Lifestyle-focused Obesity Treatment in Primary Care

Conditioning & Open-Label Placebo (COLP) for Opioid Management in Intensive Inpatient Rehabilitation

Accurate Planning and Guidance of Bronchoscopy for Lung Cancer Management

A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions

Behavioral Health Initial Intake Outreach

Retrieval-Based Word Learning in Developmental Language Disorder

Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition

Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use

BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy

Acquisition of Breast Mammography Images

Educational Video for Improving Follow-up After an Emergency Department Visit for Asthma

A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease